Non-Invasive Blood Glucose Monitoring Devices Market by Technology, Modality, and End User - Global Industry Analysis and Forecast to 2025

Report Code : HC06174

Diabetes is serious lifelong condition characterized by high blood glucose level. It is one of the most common chronic diseases across the globe that occurs either when body doesn’t produce sufficient insulin or when body fails to absorb insulin produced by pancreas. According to studies conducted by International Diabetes Federation (IDF) in 2015, around 415 million people across globe were affected with diabetes and this number is expected to reach 642 million by 2040. Moreover, diabetes incidences are rising more rapidly in middle and low income countries. This high incidence of diabetes across the globe can be attributed to various factors such as changes in lifestyle, increasing elderly population, increase in obesity rate, and family history of diabetes and related disorders. Over a period of time, diabetes affect kidney, damages heart vessels, and eyes, leading to malfunctioning of body besides people with diabetes are likely to incur huge expenditure causing financial burdens on them and family members.

Non-invasive glucose monitoring is measurement of glucose level in blood without drawing blood or puncturing the skin. People who suffer from type 1 and type 2 diabetes require frequent blood glucose monitoring, in some cases four or five times a day. However, glucose monitoring with invasive devices is both painful as well as expensive, as a result many people do not monitor their blood glucose levels very often as they should. Non-invasive monitoring devices such as wearable smart glucose monitoring devices are witnessing high adoption owing to convenience and quick output. In addition to smart wearable devices, technologies such as Raman Spectroscopy, Optical Coherence Tomography, Polarimetry and Thermal Emission Spectroscopy are non-invasive techniques used for real time blood glucose monitoring.

Rise in incidence of diabetes worldwide and increasing geriatric population with higher risk of developing chronic diseases is expected to drive growth of the market. In addition, increase in demand for non-invasive monitoring devices owing to several disadvantages imposed by invasive monitoring devices will propel growth of the market. Furthermore, technological innovations and increasing demand for better healthcare infrastructure will surge demand for non-invasive monitoring devices. However, unfavorable reimbursement policies and strict regulatory and approval norms is expected to hamper growth of the market.

Major players operating in this industry are Animas Technologies, Cercacor, Pendragon Medical, Abbott, NovioSense BV, and Bayer Healthcare. These players are focusing on developing new technologically advanced products to gain competitive advantage and to acquire larger market share. For instance in 2014, NovioSense had developed miniature electrochemical sensor that enable non-invasive glucose monitoring and is capable of detecting glucose concentration in human tears.

Increasing prevalence of diabetes and rise in demand for minimal invasive monitoring devices had forced manufacturers to develop real time and highly reliable monitoring devices. Technological advancements and increasing FDA approval for monitoring devices is expected to provide lucrative growth opportunities for market players in coming years. For instance, development of new monitoring devices such as GlucoTrack which is a non-invasive blood glucose monitor that clips to earlobe thereby eliminating the need for daily finger pricks. Furthermore, rapid advancements in smartphone and smart watches will further propel growth of the market. Emerging markets especially India and China will provide high growth opportunities for market players owing to increasing elderly population, rapidly evolving healthcare infrastructure and increasing government efforts for minimizing incidence of diabetes.

Non- Invasive Blood Glucose Monitoring Devices Market Segmentation:

By Technology

  • Raman Spectroscopy
  • MIR/NIR (Mid/Near Infrared Spectroscopy)
  • Occlusion Spectroscopy
  • Photoacoustic Spectroscopy
  • Electromagnetic
  • Thermal Emission Spectroscopy
  • Polarimetry
  • Optical Coherence Tomography
  • Fluorescence
  • Impedance/Dielectric Spectroscopy

By Modality

  • Wearable Blood Glucose Monitoring Systems
  • Non-wearable /Table top Blood Glucose Monitoring Systems

By End User

  • Clinics
  • Home Care Setting
  • Hospitals

By Region

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • Turkey
  • United Arab Emirates
  • Others

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

Licesnces Type

For Any Further Assistance

*
*
*